Several viral oncoproteins directly target these upstream kinases through a number of mechanisms ultimately attenuating their function.
The co-inhibitory receptor Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) is induced on T-cells shortly after activation and functions to attenuate their proliferation, IL-2 production, and contact time with antigen presenting cells (APC) [1], [2].
For example, GSH is the principal nucleophilic scavenger of free radicals in skeletal muscle, stabilizes other antioxidant systems, reduces proteins and helps to maintain their function, attenuates redox-sensitive catabolic factors and has salutary effects on membranes through the reduction of alcohol-induced lipid peroxidation (Jackson, 2008; Otis et al., 2007; Wu et al., 2004).
A sialylated glycoprotein called serum amyloid P (SAP) inhibits fibrocyte differentiation, and sialidases attenuate SAP function.
Classical PTPs dephosphorylate tyrosine phosphorylation to attenuate the function of many receptor tyrosine kinases (Andersen et al., 2001; Andersen et al., 2004).
To illustrate the proof of principle that ROK inhibition can attenuate platelet function, platelets were incubated for 20 min with the ROK inhibitor Y27632.
Further analysis showed that correction of hyperuricemia may attenuate renal function decline in early CKD stages (1 ~ 3a) whereas it may not attenuate renal function decline in advanced CKD stages (3b ~ 4).
However, the correction of hyperuricemia may attenuate renal function decline in some patients with mild renal insufficiency.
These data indicate that while EWS/WT1 expression appeared to attenuate p53 function, it did not directly block p53 expression.
Decreases of intracellular ATP levels attenuate the function of the HSP90 molecular chaperone; DHA treatment determines a reduction of ATP and so the disruption of the HSP90 function.
